Stereotaxis, Inc. (NYSEAMERICAN:STXS) Short Interest Down 17.3% in November

Stereotaxis, Inc. (NYSEAMERICAN:STXS) was the recipient of a significant drop in short interest in November. As of November 30th, there was short interest totalling 2,540,000 shares, a drop of 17.3% from the November 15th total of 3,070,000 shares. Approximately 3.6% of the shares of the company are short sold. Based on an average daily volume of 291,600 shares, the short-interest ratio is currently 8.7 days.

Stereotaxis Stock Performance

Shares of STXS opened at $2.34 on Friday. Stereotaxis has a 52-week low of $1.63 and a 52-week high of $3.29. The stock has a market cap of $198.27 million, a P/E ratio of -8.36 and a beta of 1.57.

Stereotaxis (NYSEAMERICAN:STXS) last posted its earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The firm had revenue of $9.20 million during the quarter, compared to analysts’ expectations of $6.80 million. Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. As a group, research analysts expect that Stereotaxis will post -0.26 EPS for the current year.

Hedge Funds Weigh In On Stereotaxis

A number of institutional investors have recently made changes to their positions in STXS. Vanguard Group Inc. lifted its position in Stereotaxis by 7.7% in the 1st quarter. Vanguard Group Inc. now owns 2,613,966 shares of the company’s stock worth $6,822,000 after buying an additional 187,437 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Stereotaxis by 46.2% during the second quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock worth $889,000 after acquiring an additional 154,400 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Stereotaxis by 247.5% during the second quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock worth $345,000 after acquiring an additional 135,041 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Stereotaxis by 7.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock worth $2,840,000 after acquiring an additional 93,253 shares during the last quarter. Finally, Barclays PLC boosted its stake in shares of Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock valued at $208,000 after purchasing an additional 83,412 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.